Australia’s health sector receives $6.4 million cyber security boost with the creation of a new threat information-sharing network

Phase III is a brand new media channel designed to share the inner-workings of the life sciences and biotechnology sector, and the bright minds it attracts.

Winners of Cooperative Research Australia’s Excellence in Innovation Awards showcasing the positive impact Australia’s established industry-research collaborations have.

Curtin University research is aiming to combine artificial intelligence with natural, infection-fighting viruses to help save lives from an increasingly common medical emergency found in hospitals.

New Griffith University site for the Translational Science Hub brings global vaccine R&D to the Gold Coast.

A new antimicrobial suture material that glows in medical imaging could provide a promising alternative for mesh implants and internal stitches. 

RMIT scientists have created a new type of antibiotic that can be rapidly re-engineered to avoid resistance by dangerous superbugs.  

Shake It Up Australia Foundation offers World Parkinson’s Congress travel grants to early career researchers.

Health is failing to cut through in the media coverage and on social platforms despite the country being in the midst of a pandemic.

Study led by Monash University scientists has found that a combination of phages and antibiotics may be far more effective against bacterial infections.

Australia’s biotechnology sector has united to launch a strategy for the Australian Biotechnology Industry

The innovative, non-invasive therapy utilises the radioisotope Rhenium-188 and is applied only to the area requiring treatment, sparing healthy tissue.

As demand for alternative protein sources grows, Australians are increasingly looking for options that are healthy, sustainable and ethically made.

Projects to develop an mRNA vaccine for bacterial infections and a device to treat heart failure share in more than $32 million in funding

Basic science is far more than the translatable research outcomes it might enable. It is also the catalyst for significant advances in our social and economic wellbeing. 

Building on fundamental gene technologies, Australian scientists have adapted a treatment for children’s cancer into a tool to target and suppress the virus that causes COVID-19.

From fundamental cellular studies in the 1950s, synthetic biology will become a multi-billion-dollar opportunity in coming decades.

Australian designed, sustainable scrubs made from 48% recycled post-consumer water bottles.

Australia company Bionic Vision Technologies is in the race to produce the first bionic eye.

New imaging software can accurately diagnose jaundice in newborn babies and set treatment in action.

Register for the next ANSTO x Science Meets Business Innovation Series exploring how nuclear is medicine delivering improvements in human health and the treatment and diagnosis of cancer.

The two leading nuclear medicine enterprises have come together to develop, manufacture and supply radiopharmaceuticals for cancer treatments.

The Prime Minister’s Prizes for Science are Australia’s most prestigious awards for outstanding achievements in scientific research, research-based innovation, and excellence in science teaching.

Innovative microscope slide promises to revolutionise medical imaging.